» Articles » PMID: 30258624

Frequency of Bloodstream Infection in Febrile Neutropenic Patients, Experience from a Developing Country

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2018 Sep 28
PMID 30258624
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: About 20% of febrile neutropenic patients are presented with bloodstream infection which is a leading cause of mortality among these patients. Awareness of the locally prevalent pathogens and their susceptibility pattern is important for proper treatment of infection which improves survival in these patients. The objective of this study was to determine the frequency of bloodstream infection in patients with febrile neutropenia admitted in Abbasi Shaheed Hospital.

Methods: This cross-sectional study was conducted in the Medical wards in Abbasi Shaheed Hospital, Karachi from 21-2-2016 to 20-8-2017. Patients of over 15 years of age of either gender with severe neutropenia were included in this study. Patients with noninfectious cause of fever, or fever prior to neutropenia were excluded. Patients meeting inclusion criteria were enrolled after taking informed consent. About 2-5 ml blood was collected under aseptic measures in Bactac culture bottles. Blood samples were sent to lab within 30 min of collection. Antimicrobial sensitivity testing of all isolates was performed on diagnostic Sensitivity test plates by Kerby - Bauer Method. Patients were referred back to treating physician if blood culture is positive. The data was analyzed using SPSS version 20.

Results: Of 200 patients, the mean age was 25.8 ± 5.7 years, 120 (60%) were male with male to female ratio of 1.5:1, 89 (44.5%) had low grade fever (Temp. ≤102 °C) and 111 (55.5%) had high grade fever(Temp. >102 °C). The frequency of was 16%, was 14.5%, 8.5% and 15.5.

Conclusions: It is concluded that the frequency of was 16%, was 14.5%, 8.5% and 15.5.

Citing Articles

Evaluation of Blood Culture Results in Patients with Malignancy in Erzurum Province, Turkey.

Aktas O, Akbaba O, Uyanik M, Uslu H Acta Med Litu. 2024; 31(1):128-139.

PMID: 38978849 PMC: 11227679. DOI: 10.15388/Amed.2024.31.1.17.


Bacterial spectrum and antimicrobial resistance pattern in cancer patients with febrile neutropenia.

Darakhshandeh A, Fathi E, Gholami A, Ashrafi F, Mehrzad V, Nasri E Int J Biochem Mol Biol. 2023; 14(1):10-16.

PMID: 36936611 PMC: 10018003.

References
1.
Grann V, Bowman N, Joseph C, Wei Y, Horwitz M, Jacobson J . Neutropenia in 6 ethnic groups from the Caribbean and the U.S. Cancer. 2008; 113(4):854-60. DOI: 10.1002/cncr.23614. View

2.
Hughes W, Armstrong D, Bodey G, Bow E, Brown A, Calandra T . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34(6):730-51. DOI: 10.1086/339215. View

3.
Steele R . Managing infection in cancer patients and other immunocompromised children. Ochsner J. 2012; 12(3):202-10. PMC: 3448241. View

4.
Naseem A, Hussain Y, Ahmad B, Aziz M, Ahmad M, Hameed H . A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients. J Pak Med Assoc. 2012; 61(1):18-22. View

5.
Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View